| abstract |
A variety of assessment methods are disclosed herein that can assess whether an individual has an ovarian tumor, a malignant ovarian tumor, or an individual's prognosis based on the highly methylated status of one or more genetic markers. Furthermore, various assay methods are disclosed herein for determining whether a tissue sample obtained from an individual has cell proliferation; the tissue sample is a bladder sample, a breast sample, a cervical scraping sample, a large intestine sample, an endometrial sample, a liver Sample, oral scraping sample or osteosarcoma sample. |